Sharad Goyal, MD
Radiation Oncology · New Brunswick, NJNPI 1447416417
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 95 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 21 manufacturers reported payments, led by Sumitomo Pharma America, Inc. at 35.7% of the total.
Across 95 payments — averaging $36.07 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Sumitomo Pharma America, Inc.$1K
- Boston Scientific$525
- Myovant Sciences Inc.$217
- Viewray Technologies Inc$160
- GT Medical Technologies, Inc$157
- AstraZeneca$149
- plus $996 from 15 others
What the payments were for
- Food & beverage$3,426100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Sumitomo Pharma America, Inc. | 29 | $1,222 |
| Boston Scientific | 13 | $525 |
| Myovant Sciences Inc. | 10 | $217 |
| Viewray Technologies Inc | 1 | $160 |
| GT Medical Technologies, Inc | 1 | $157 |
| AstraZeneca | 5 | $149 |
| Merck | 5 | $138 |
| Novocure Inc. | 5 | $136 |
| Tactile Systems Technology Inc | 3 | $108 |
| Reflexion Medical, Inc. | 3 | $96 |
| Monteris Medical Corporation | 3 | $84 |
| Siemens Medical Solutions USA, Inc. | 3 | $79 |
| Teleflex LLC | 2 | $70 |
| Seagen Inc. | 3 | $63 |
| Novartis | 2 | $57 |
| Pfizer | 2 | $46 |
| Varian Medical Systems, Inc. | 1 | $32 |
| Springworks Therapeutics, Inc. | 1 | $26 |
| Johnson & Johnson | 1 | $26 |
| Progenics Pharmaceuticals, Inc. | 1 | $18 |
| Fortovia Therapeutics, Inc. | 1 | $17 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- ORGOVYX$447
- MRIdian$160
- GammaTile$157
- TheraSphere Y90 Glass Microspheres 10 GBq$144
How this compares
$3,426 in reported general payments places this provider in the 85th percentile of 132 radiation oncology providers in New Jersey.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other radiation oncology in New Brunswick
- Salma JabbourNew Brunswick$163K
- Atif KhanNew Brunswick$2K
- Bruce HafftyNew Brunswick$1K
- Lara HathoutNew Brunswick$592
- Michael GreenbergCherry Hill$335K
- Glen GejermanHackensack$180K
- Marc RudoltzWest Orange$166K
- Edward SoffenMonroe Twp$50K
- Adnan DanishWayne$45K
- Timothy ChenPennington$43K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.